Hippocalcin‐like 1 suppresses hepatocellular carcinoma progression by promoting p21Waf/Cip1 stabilization by activating the ERK1/2‐MAPK pathway
Yonglong Zhang, Jie Liu(Huashan Hospital), Huilu Zhang(Fudan University), Haibo Yan(Shanghai Medical College of Fudan University), Jun Zhang(Shantou University Medical College), Yanfeng Liu(Shanghai Jiao Tong University), Qi Fan(Eye & ENT Hospital of Fudan University), Ke Qiao(Shanghai Medical College of Fudan University), Jinlin Duan(Tongren Hospital), Guoquan Yan(Shanghai Medical College of Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine)
Cited by 58
Related Papers
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
|Nature Communications|2020|273
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
|Cancer Immunology Research|2018|137